Ginkgo Bioworks (NYSE:DNA) Trading Down 5.4% – Here’s What Happened

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)’s share price fell 5.4% during mid-day trading on Wednesday . The company traded as low as $11.21 and last traded at $11.72. 649,797 shares were traded during mid-day trading, a decline of 58% from the average session volume of 1,534,823 shares. The stock had previously closed at $12.38.

Ginkgo Bioworks Stock Performance

The firm’s 50-day moving average price is $11.12.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. SBI Securities Co. Ltd. bought a new stake in shares of Ginkgo Bioworks in the 4th quarter worth approximately $29,000. KBC Group NV purchased a new stake in Ginkgo Bioworks in the fourth quarter worth $31,000. KLP Kapitalforvaltning AS bought a new stake in Ginkgo Bioworks in the fourth quarter valued at $46,000. Bank of New York Mellon Corp increased its position in Ginkgo Bioworks by 48.2% during the 4th quarter. Bank of New York Mellon Corp now owns 23,061 shares of the company’s stock valued at $226,000 after purchasing an additional 7,503 shares during the period. Finally, Monaco Asset Management SAM raised its holdings in Ginkgo Bioworks by 3.9% in the 4th quarter. Monaco Asset Management SAM now owns 384,664 shares of the company’s stock worth $3,777,000 after purchasing an additional 14,539 shares in the last quarter. Institutional investors own 78.63% of the company’s stock.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.